{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:16:02Z","timestamp":1785420962882,"version":"3.56.0"},"reference-count":44,"publisher":"Rockefeller University Press","issue":"3","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,4]]},"abstract":"<jats:p>Chronic granulomatous disease (CGD) is an inborn error of immunity leading to severe invasive mold infections (IMIs). Questions remain regarding the safety of hematopoietic stem cell transplantation (HSCT) in patients following IMI. We retrospectively collected data from CGD patients undergoing HSCT within 2 years after a diagnosis of probable or proven IMI in France. The primary endpoint was to describe 1-year overall survival (OS). 14 patients were included, with aspergillosis (n = 10), mucormycosis (N = 2), scedosporiosis, or lomentosporiosis (n = 1 each). IMI status at time of HCST included four in complete response, four in partial response (PR), one in stable response (SR), and five with disease progression (DP). 1-year OS was 86 % (12\/14). Two patients with scedosporiosis and lomentosporiosis died before engraftment. The remaining patients all achieved engraftment followed by prolonged clinical response of IMI. HSCT appears safe in patients with complete response or PR of IMI and could be a promising curative option for progressive IMI, specifically in those with invasive aspergillosis.<\/jats:p>","DOI":"10.70962\/jhi.20250164","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T07:21:46Z","timestamp":1770794506000},"update-policy":"https:\/\/doi.org\/10.70962\/jhi.crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Hematopoietic stem cell transplantation following invasive mold infection in chronic granulomatous disease: Insights from a case series and literature review"],"prefix":"10.70962","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8881-9414","authenticated-orcid":true,"given":"Hugo","family":"Bes-Berlandier","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05tr67282","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris Cit\u00e9, Service de Maladies Infectieuses et Tropicales, H\u00f4pital Necker\u2013Enfants Malades 1 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3975-3136","authenticated-orcid":true,"given":"Olivier","family":"Paccoud","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05tr67282","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris Cit\u00e9, Service de Maladies Infectieuses et Tropicales, H\u00f4pital Necker\u2013Enfants Malades 1 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8941-0935","authenticated-orcid":true,"given":"Benedicte","family":"Neven","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05tr67282","id-type":"ROR","asserted-by":"publisher"}],"name":"Pediatric Immuno-Hematology and Rheumatology Unit, Necker-Enfants University Hospital, Assistance Publique-H\u00f4pitaux de Paris 2 , Paris,","place":["France"]},{"name":"Imagine, U1168, Immunogenetics of Autoimmune Diseases 3 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4721-2740","authenticated-orcid":true,"given":"Marie Elisabeth","family":"Bougnoux","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05tr67282","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris Cit\u00e9, Service de Mycologie-Parasitologie, H\u00f4pital Necker\u2013Enfants Malades 4 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6141-1845","authenticated-orcid":true,"given":"Emilie","family":"Sitterl\u00e9","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05tr67282","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris Cit\u00e9, Service de Mycologie-Parasitologie, H\u00f4pital Necker\u2013Enfants Malades 4 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6844-7920","authenticated-orcid":true,"given":"Ambroise","family":"Marcais","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05tr67282","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris Cit\u00e9, Service D\u2019h\u00e9matologie Adultes, H\u00f4pital Necker\u2013Enfants Malades, Assistance Publique-H\u00f4pitaux de Paris 5 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2070-9581","authenticated-orcid":true,"given":"Morgane","family":"Cheminant","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05tr67282","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris Cit\u00e9, Service D\u2019h\u00e9matologie Adultes, H\u00f4pital Necker\u2013Enfants Malades, Assistance Publique-H\u00f4pitaux de Paris 5 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6719-3693","authenticated-orcid":true,"given":"Despina","family":"Moshous","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05tr67282","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris Cit\u00e9, Service D\u2019h\u00e9matologie Adultes, H\u00f4pital Necker\u2013Enfants Malades, Assistance Publique-H\u00f4pitaux de Paris 5 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3015-0846","authenticated-orcid":true,"given":"Rinzine","family":"Sammut","sequence":"additional","affiliation":[{"name":"Service D\u2019h\u00e9matologie Clinique 6 , Centre Hospitalier Universitaire de Nice, Nice,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8801-4164","authenticated-orcid":true,"given":"Pierre Simon","family":"Rohrlich","sequence":"additional","affiliation":[{"name":"Service D\u2019h\u00e9matologie Clinique 6 , Centre Hospitalier Universitaire de Nice, Nice,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0030-8094","authenticated-orcid":true,"given":"Nizar","family":"Mahlaoui","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05tr67282","id-type":"ROR","asserted-by":"publisher"}],"name":"Pediatric Immuno-Hematology and Rheumatology Unit, Necker-Enfants University Hospital, Assistance Publique-H\u00f4pitaux de Paris 2 , Paris,","place":["France"]},{"id":[{"id":"https:\/\/ror.org\/05tr67282","id-type":"ROR","asserted-by":"publisher"}],"name":"French National Reference Center for Primary Immunodeficiencies, Necker-Enfants University Hospital, Assistance Publique-H\u00f4pitaux de Paris 7 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8325-8060","authenticated-orcid":true,"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05tr67282","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris Cit\u00e9, Service de Maladies Infectieuses et Tropicales, H\u00f4pital Necker\u2013Enfants Malades 1 , Paris,","place":["France"]},{"name":"Imagine, U1168, Immunogenetics of Autoimmune Diseases 3 , Paris,","place":["France"]},{"name":"Centre National de R\u00e9f\u00e9rence des Mycoses Invasives et Antifongiques, Institut Pasteur 8 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3537-9052","authenticated-orcid":true,"given":"Felipe","family":"Suarez","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05tr67282","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris Cit\u00e9, Service D\u2019h\u00e9matologie Adultes, H\u00f4pital Necker\u2013Enfants Malades, Assistance Publique-H\u00f4pitaux de Paris 5 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3800-4683","authenticated-orcid":true,"given":"Fanny","family":"Lanternier","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05tr67282","id-type":"ROR","asserted-by":"publisher"}],"name":"Universit\u00e9 Paris Cit\u00e9, Service de Maladies Infectieuses et Tropicales, H\u00f4pital Necker\u2013Enfants Malades 1 , Paris,","place":["France"]},{"name":"Centre National de R\u00e9f\u00e9rence des Mycoses Invasives et Antifongiques, Institut Pasteur 8 , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"2026030515421791300_bib1","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jaip.2016.03.021","article-title":"A comprehensive approach to the management of children and adults with chronic granulomatous disease","volume":"4","author":"Thomsen","year":"2016","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"2026030515421791300_bib2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/jof2020015","article-title":"Aspergillosis in chronic granulomatous disease","volume":"2","author":"King","year":"2016","journal-title":"J. Fungi"},{"key":"2026030515421791300_bib3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-1-4614-4726-9_3","article-title":"Invasive fungal infections in patients with chronic granulomatous disease","volume":"764","author":"Henriet","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"2026030515421791300_bib4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.clim.2007.09.008","article-title":"Clinical features, long-term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: An Italian multicenter study","volume":"126","author":"Martire","year":"2008","journal-title":"Clin. Immunol."},{"key":"2026030515421791300_bib5","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1093\/cid\/cir731","article-title":"Invasive mold infections in chronic granulomatous disease: A 25-year retrospective survey","volume":"53","author":"Blumental","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"2026030515421791300_bib6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","article-title":"Chronic granulomatous disease. Report on a national registry of 368 patients","volume":"79","author":"Winkelstein","year":"2000","journal-title":"Medicine"},{"key":"2026030515421791300_bib7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-2249.2008.03644.x","article-title":"Special article: Chronic granulomatous disease in the United Kingdom and Ireland: A comprehensive national patient-based registry","volume":"152","author":"Jones","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"2026030515421791300_bib8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12281-019-00339-5","article-title":"Non-Aspergillus fungal infections in chronic granulomatous disease","volume":"13","author":"Guery","year":"2019","journal-title":"Curr. Fungal Infect. Rep."},{"key":"2026030515421791300_bib9","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/cid\/ciw837","article-title":"Chronic granulomatous disease in patients reaching adulthood: A nationwide study in France","volume":"64","author":"Dunogu\u00e9","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"2026030515421791300_bib10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1182\/blood.2022015482","article-title":"Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunity","volume":"141","author":"Cheminant","year":"2023","journal-title":"Blood"},{"key":"2026030515421791300_bib11","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/pai.13402","article-title":"Outcome of chronic granulomatous disease - conventional treatment vs stem cell transplantation","volume":"32","author":"Dedieu","year":"2021","journal-title":"Pediatr. Allergy Immunol."},{"key":"2026030515421791300_bib12","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1182\/blood.2020005590","article-title":"Hematopoietic cell transplantation in chronic granulomatous disease: A study of 712 children and adults","volume":"136","author":"Chiesa","year":"2020","journal-title":"Blood"},{"key":"2026030515421791300_bib13","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1182\/blood-2002-02-0583","article-title":"Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: A survey of the European experience, 1985-2000","volume":"100","author":"Seger","year":"2002","journal-title":"Blood"},{"key":"2026030515421791300_bib14","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"2026030515421791300_bib15","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: Working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"2026030515421791300_bib16","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1093\/annonc\/mdx274","article-title":"Reduced-intensity versus reduced-toxicity myeloablative fludarabine\/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Soci\u00e9t\u00e9 Francophone de Greffe de Moelle et de Th\u00e9rapie Cellulaire","volume":"28","author":"Le Bourgeois","year":"2017","journal-title":"Ann. Oncol."},{"key":"2026030515421791300_bib17","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/bmt.2014.133","article-title":"Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: A report from the acute Leukemia working party of EBMT","volume":"49","author":"Kharfan-Dabaja","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"2026030515421791300_bib18","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.1182\/blood.v99.12.4618","article-title":"Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction","volume":"99","author":"Alizadeh","year":"2002","journal-title":"Blood"},{"key":"2026030515421791300_bib19","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41409-024-02251-0","article-title":"Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: A report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT","volume":"59","author":"Sureda","year":"2024","journal-title":"Bone Marrow Transplant."},{"key":"2026030515421791300_bib20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"2026030515421791300_bib21","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1086\/590566","article-title":"Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria","volume":"47","author":"Segal","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"2026030515421791300_bib22","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1038\/s41409-022-01739-x","article-title":"Curative allogeneic hematopoietic stem cell transplantation following reduced toxicity conditioning in adults with primary immunodeficiency","volume":"57","author":"Mar\u00e7ais","year":"2022","journal-title":"Bone Marrow Transplant."},{"key":"2026030515421791300_bib23","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S0140-6736(13)62069-3","article-title":"Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: A prospective multicentre study","volume":"383","author":"G\u00fcng\u00f6r","year":"2014","journal-title":"Lancet"},{"key":"2026030515421791300_bib24","doi-asserted-by":"publisher","first-page":"1307932","DOI":"10.3389\/fimmu.2024.1307932","article-title":"Hematopoietic stem cell transplantation in children with chronic granulomatous disease: The Spanish experience","volume":"15","author":"Alonso Garc\u00eda","year":"2024","journal-title":"Front. Immunol."},{"key":"2026030515421791300_bib25","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1182\/blood.2022019586","article-title":"Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD","volume":"142","author":"Leiding","year":"2023","journal-title":"Blood"},{"key":"2026030515421791300_bib26","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1182\/blood.2024026915","article-title":"HLA-Haploidentical stem cell transplantation for chronic granulomatous disease: An EBMT-IEWP retrospective study","volume":"145","author":"Riller","year":"2025","journal-title":"Blood"},{"key":"2026030515421791300_bib27","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1182\/blood-2009-10-249219","article-title":"The impact of anti-HLA antibodies on unrelated cord blood transplantations","volume":"116","author":"Takanashi","year":"2010","journal-title":"Blood"},{"key":"2026030515421791300_bib28","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/sj.bmt.1702651","article-title":"Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation","volume":"26","author":"Bielorai","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"2026030515421791300_bib29","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s10875-020-00772-z","article-title":"Failure to prevent severe graft-versus-host disease in haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in chronic granulomatous disease","volume":"40","author":"Parta","year":"2020","journal-title":"J. Clin. Immunol."},{"key":"2026030515421791300_bib30","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1182\/blood.V92.8.2719","article-title":"Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B","volume":"92","author":"Ozsahin","year":"1998","journal-title":"Blood"},{"key":"2026030515421791300_bib44","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/jcp.55.10.784","article-title":"Scedosporium apiospermum in chronic granulomatous disease treated with an HLA matched bone marrow transplant","volume":"55","author":"Gompels","year":"2002","journal-title":"J. Clin. Pathol."},{"key":"2026030515421791300_bib32","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/pbc.20865","article-title":"Allogeneic bone marrow transplantation with reduced intensity conditioning for chronic granulomatous disease complicated by invasive Aspergillus infection","volume":"47","author":"Sastry","year":"2006","journal-title":"Pediatr. Blood Cancer"},{"key":"2026030515421791300_bib33","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s12185-009-0433-z","article-title":"Treosulfan-based conditioning regimen in a second matched unrelated peripheral blood stem cell transplantation for a pediatric patient with CGD and invasive aspergillosis, who experienced initial graft failure after RIC","volume":"90","author":"Klaudel-Dreszler","year":"2009","journal-title":"Int. J. Hematol."},{"key":"2026030515421791300_bib39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12026-008-8068-3","article-title":"Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease","volume":"44","author":"Schuetz","year":"2009","journal-title":"Immunol. Res."},{"key":"2026030515421791300_bib40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1365-2141.2009.07614.x","article-title":"Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth","volume":"145","author":"Soncini","year":"2009","journal-title":"Br. J. Haematol."},{"key":"2026030515421791300_bib41","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s12185-011-0932-6","article-title":"Successful allogeneic hematopoietic stem cell transplantation for chronic granulomatous disease with inflammatory complications and severe infection","volume":"94","author":"Kato","year":"2011","journal-title":"Int. J. Hematol."},{"key":"2026030515421791300_bib34","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s10875-011-9513-y","article-title":"Allogeneic haematopoietic stem cell transplantation as therapy for chronic granulomatous disease--single centre experience","volume":"31","author":"Go\u017adzik","year":"2011","journal-title":"J. Clin. Immunol."},{"key":"2026030515421791300_bib35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jaci.2011.10.005","article-title":"Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease","volume":"129","author":"Martinez","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"2026030515421791300_bib36","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/apa.12384","article-title":"Chronic granulomatous disease-haematopoietic stem cell transplantation versus conventional treatment","volume":"102","author":"\u00c5hlin","year":"2013","journal-title":"Acta Paediatr."},{"key":"2026030515421791300_bib37","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/trf.12325","article-title":"Successful cord blood transplantation after repeated transfusions of unmobilized neutrophils in addition to antifungal treatment in an infant with chronic granulomatous disease complicated by invasive pulmonary aspergillosis","volume":"54","author":"Shigemura","year":"2014","journal-title":"Transfusion"},{"key":"2026030515421791300_bib31","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/INF.0000000000003109","article-title":"Hematopoietic stem cell transplantation cures therapy-refractory aspergillosis in chronic granulomatous disease","volume":"40","author":"Dedieu","year":"2021","journal-title":"Pediatr. Infect. Dis. J."},{"key":"2026030515421791300_bib42","doi-asserted-by":"publisher","first-page":"278","DOI":"10.12932\/AP-290419-0551","article-title":"Successful haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide in a child with X-linked chronic granulomatous disease: A first report in Asia","volume":"40","author":"Janjindamai","year":"2022","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"2026030515421791300_bib38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41409-024-02389-x","article-title":"Outcomes in hematopoetic cell transplantation in the setting of mold infections in patients with chronic granulomatous disease","volume":"60","author":"Kline","year":"2025","journal-title":"Bone Marrow Transplant."},{"key":"2026030515421791300_bib43","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s10875-025-01903-0","article-title":"Consecutive non-Aspergillus fungal invasive infections in chronic granulomatous disease: Data from the French national reference center for primary ImmunoDeficiencies and literature review","volume":"45","author":"Lefevre","year":"2025","journal-title":"J. Clin. Immunol."}],"container-title":["Journal of Human Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jhi\/article-pdf\/doi\/10.70962\/jhi.20250164\/2027829\/jhi_20250164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jhi\/article-pdf\/doi\/10.70962\/jhi.20250164\/2027829\/jhi_20250164.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T20:42:22Z","timestamp":1772743342000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jhi\/article\/2\/3\/e20250164\/281540\/Hematopoietic-stem-cell-transplantation-following"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5,4]]}},"URL":"https:\/\/doi.org\/10.70962\/jhi.20250164","relation":{},"ISSN":["3065-8993"],"issn-type":[{"value":"3065-8993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"article-number":"e20250164"}}